APA (7th ed.) Citation

Sant, M., Vener, C., Lillini, R., Rossi, S., Bonfarnuzzo, S., Marcos-Gragera, R., . . . De Angelis, R. (2024). Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): A retrospective, population-based study. Lancet Oncology, 25(6), 731. https://doi.org/10.1016/S1470-2045(24)00141-4

Chicago Style (17th ed.) Citation

Sant, Milena, et al. "Long-term Survival for Lymphoid Neoplasms and National Health Expenditure (EUROCARE-6): A Retrospective, Population-based Study." Lancet Oncology 25, no. 6 (2024): 731. https://doi.org/10.1016/S1470-2045(24)00141-4.

MLA (9th ed.) Citation

Sant, Milena, et al. "Long-term Survival for Lymphoid Neoplasms and National Health Expenditure (EUROCARE-6): A Retrospective, Population-based Study." Lancet Oncology, vol. 25, no. 6, 2024, p. 731, https://doi.org/10.1016/S1470-2045(24)00141-4.